Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 03, 2024

SELL
$161.01 - $317.85 $805 - $1,589
-5 Reduced 35.71%
9 $2,000
Q3 2023

Oct 03, 2023

BUY
$164.66 - $218.08 $823 - $1,090
5 Added 55.56%
14 $2,000
Q2 2023

Aug 01, 2023

BUY
$176.32 - $240.22 $528 - $720
3 Added 50.0%
9 $1,000
Q4 2022

Jan 06, 2023

BUY
$191.53 - $236.82 $191 - $236
1 Added 20.0%
6 $1,000
Q1 2022

Apr 08, 2022

BUY
$98.9 - $132.37 $494 - $661
5 New
5 $1,000

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.